At the end of this study, it was considered that CRP level values measured preoperatively in blood serum of patients with solitary intracranial tumor could be a strong predictive biomarker in distinguishing metastatic brain tumor from glioblastoma. This evidence concerns the gene CRP and glioblastoma.